ArticleJournal for vascular ultrasound : JVU2025
Clinical Risk Factors for Stroke and Associations with Microembolic Signals on Transcranial Doppler.
Article in Journal for vascular ultrasound : JVU, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Introduction: Transcranial Doppler (TCD) has been used to identify microembolic signals (MES) in individuals with carotid atherosclerosis (CAS). MES are hypothesized to originate from unstable carotid plaque and have been identified in symptomatic and asymptomatic individuals with CAS. The purpose of this study is to examine the relationship of clinical risk factors for stroke (CRFs) and the presence of MES in patients with advanced CAS. Methods: Participants scheduled for carotid endarterectomy (CEA) (>60% stenosis NASCET and ACAS Criteria) were preoperatively evaluated for CRFs and the presence MES with TCD. Kendall's tau correlation coefficients, Pearson χ2, and logistic regression analysis were used to examine the relationship between MES and CRFs. Results: Participants (n=89) had a median (interquartile range) age of 71(13) years, 30 (33.7%) were female, and 53(59.6%) were symptomatic. MES were detected in 32 (36%) participants. There was significant evidence of association between MES with older age (p =0.026) and male sex (p =0.007). No other clinical variables showed significant association with MES (all p-values>0.05). Logistic regression demonstrated that a model including age(p=0.018), sex(p=0.013) and hyperlipidemia(p=0.083) was significantly associated with the presence of MES (p=0.001). Conclusion: MES were associated with older age and male sex in a cohort with advanced carotid atherosclerosis. Symptomatic status was not a predictor for MES in this cohort, suggesting that plaques in both symptomatic and asymptomatic individuals have the ability to release microemboli, highlighting the need for further work to be done to identify unstable plaques.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.